ClinicalThought

Share

Program Content

Activities

  • BTKi in MCL/MZL
    How I Use BTK Inhibitors to Treat Patients With MCL and MZL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 03, 2020

    Expires: March 02, 2021

  • BTK Inhibitors in WM
    How I Use BTK Inhibitors to Treat My Patients With Waldenström Macroglobulinemia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 31, 2020

    Expires: March 30, 2021

  • BTK Inhibitors for CLL
    How I Use BTK Inhibitors to Treat My Patients With CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 24, 2020

    Expires: April 23, 2021

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

cover img faculity

Prashant Kapoor, MD

Assistant Professor of Medicine and Oncology
Consultant
Department of Hematology
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Supporters

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics AbbVie